Study on Maximum Specific Loss Power in Fe3O4 Nanoparticles Decorated with Biocompatible Gamma-Cyclodextrins for Cancer Therapy with Superparamagnetic Hyperthermia

Int J Mol Sci. 2021 Sep 17;22(18):10071. doi: 10.3390/ijms221810071.

Abstract

Different chemical agents are used for the biocompatibility and/or functionality of the nanoparticles used in magnetic hyperthermia to reduce or even eliminate cellular toxicity and to limit the interaction between them (van der Waals and magnetic dipolar interactions), with highly beneficial effects on the efficiency of magnetic hyperthermia in cancer therapy. In this paper we propose an innovative strategy for the biocompatibility of these nanoparticles using gamma-cyclodextrins (γ-CDs) to decorate the surface of magnetite (Fe3O4) nanoparticles. The influence of the biocompatible organic layer of cyclodextrins, from the surface of Fe3O4 ferrimagnetic nanoparticles, on the maximum specific loss power in superparamagnetic hyperthermia, is presented and analyzed in detail in this paper. Furthermore, our study shows the optimum conditions in which the magnetic nanoparticles covered with gamma-cyclodextrin (Fe3O4-γ-CDs) can be utilized in superparamagnetic hyperthermia for an alternative cancer therapy with higher efficiency in destroying tumoral cells and eliminating cellular toxicity.

Keywords: Brown relaxation; Néel magnetic relaxation; alternative cancer therapy; magnetite nanoparticles; maximum specific loss power; superparamagnetic hyperthermia; γ-cyclodextrins.

MeSH terms

  • Biocompatible Materials / chemistry*
  • Cell Line, Tumor
  • Ferric Compounds / chemistry*
  • Humans
  • Hyperthermia, Induced
  • Magnetics
  • Magnetite Nanoparticles
  • Metal Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • X-Ray Diffraction
  • gamma-Cyclodextrins / chemistry*

Substances

  • Biocompatible Materials
  • Ferric Compounds
  • Magnetite Nanoparticles
  • gamma-Cyclodextrins
  • ferric oxide
  • gamma-cyclodextrin